ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve

计划入组 131 人 · 首次发布于 2024 年 7 月 9 日

HEAL-IST IDE Trial

计划入组 142 人 · 首次发布于 2022 年 3 月 15 日

BoxX-NoAF Clinical Trial

计划入组 960 人 · 首次发布于 2025 年 5 月 25 日

Xeno-Skin

Biological isolate (United Paragon Associates)

CHARISMA SKIN

United States

Skin Elements Ltd

Nu Skin Enterprises

United States

Halo Pharma Emerges as Independent CDMO Following Noramco Group Divestiture to Siegfried

Noramco Group Invests $25 Million to Establish Sterile Injectable Manufacturing in New Jersey

Jubilant Pharmova Receives US FDA Approval for New Isolator-Based Fill-and-Finish Line at Spokane Facility